YN8-32442-70697
2 vaccinations
1 coded response
7 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 324 / FL
- Registered
- 2021-07-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-12
Dose 1 — Moderna
-
2021-07-16
Registered in v-safe
- 2021-07-16
- 2021-07-17
- 2021-07-18
- 2021-07-19
-
2021-08-05
Dose 2 — Moderna
-
2021-08-06
Survey response — day 21, dose 1MedDRA: Chills, Fatigue, Headache, Hyperhidrosis, Myalgia — Feeling: Poor · Be unable to do your normal daily activitiesFree text: After second covid vaccine, chills, sweating, fatigue, muscle soreness, headache.MedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-09-11
- 2022-08-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-12 | Moderna | No |
| 2 | 2021-08-05 | Moderna | No |
Free text
Release 9 — day 21, dose 1
Symptoms: After second covid vaccine, chills, sweating, fatigue, muscle soreness, headache.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | ✓ | · | ✓ |
| SD | Fatigue | ✓ | · | ✓ |
| SD | Headache | ✓ | · | ✓ |
| SD | Hyperhidrosis | ✓ | · | ✓ |
| SD | Myalgia | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release